Innate Pharma S.A. Gains 34%

Tue, Jun 21, 2022 at 08:21 PM
Innate Pharma S.A. Gains 34%

Innate Pharma S.A. (IPHA:NASDAQ) jumped higher at $2.68, representing a gain of 34%. The stock got featured on our News Catalysts scanner on Fri, Jun 03, 2022 at 03:13 AM in the 'BIOTECH' category. From Tue, Jun 07, 2022, the stock recorded 22.22% Up Days and 10.00% Green Days

About Innate Pharma S.A. (IPHA:NASDAQ)

Innate Pharma SA is a clinical-stage biotechnology company. The company is engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. It specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by mobilizing the power of the body's immune system to recognize and kill cancer cells. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.